The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Complementary Roles of Farnesoid X Receptor, Pregnane X Receptor, and Constitutive Androstane Receptor in Protection against Bile Acid Toxicity
Open accessAbstract
The nuclear receptors, farnesoid X receptor (FXR) and pregnane X receptor (PXR), are important in maintaining bile acid homeostasis. Deletion of both FXR and PXR in vivo by cross-breeding B6;129-Fxrtm1Gonz (FXR-null) and B6;129-Pxrtm1Glaxo-Wellcome (PXR-null) mice revealed a more severe disruption of bile acid, cholesterol, and lipid homeostasis in B6;129-Fxrtm1Gonz Pxrtm1Glaxo-Wellcome (FXR-PXR double null or FPXR-null) mice fed a 1% cholic acid (CA) diet. Hepatic expression of the constitutive androstane receptor (CAR) and its target genes was induced in FXR- and FPXR-null mice fed the CA diet. To test whether up-regulation of CAR represents a means of protection against bile acid toxicity to compensate for the loss of FXR and PXR, animals were pretreated with CAR activators, phenobarbital or 1,4-bis[2-(3,5-dichlorpyridyloxy)]benzene (TCPOBOP), followed by the CA diet. A role for CAR in protection against bile acid toxicity was confirmed by a marked reduction of serum bile acid and bilirubin concentrations, with an elevation of the expression of the hepatic genes involved in bile acid and/or bilirubin metabolism and excretion (CYP2B, CYP3A, MRP2, MRP3, UGT1A, and glutathione S-transferase alpha), following pretreatment with phenobarbital or TCPOBOP. In summary, the current study demonstrates a critical and combined role of FXR and PXR in maintaining not only bile acid but also cholesterol and lipid homeostasis in vivo. Furthermore, FXR, PXR, and CAR protect against hepatic bile acid toxicity in a complementary manner, suggesting that they serve as redundant but distinct layers of defense to prevent overt hepatic damage by bile acids during cholestasis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Elevated BAs can activate the FXR, pregnane X receptor (PXR), and CAR.54,55”
From Constitutive Androstane Receptor Regulates Bile Acid Homeostasis and Metabolism During Liver Regeneration (2026) · cites this paper as [55]
In the citing paper
“Intrahepatic cholestasis can also activate the constitutive androstane receptor (CAR, NR1I3) (Guo et al., 2003; Huang et al., 2005; Ma et al., 2009; Zhang et al., 2004)”
From Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis (2016) · cites this paper as Guo et al., 2003
In the citing paper
“We and others have previously demonstrated that elevated bile acids, as observed in mice lacking circadian homeostasis, activates CAR (Guo et al., 2003; Huang et al., 2005; Ma et al., 2009; Zhang et al., 2004)”
From Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis (2016) · cites this paper as Guo et al., 2003
In the citing paper
“which is well known as a potent tumor promoter that drives non-genotoxic hepatocarcinogenesis (Guo et al., 2003; Huang et al., 2005; Yamamoto et al., 2004; Zhang et al., 2004).”
From Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis (2016) · cites this paper as Guo et al., 2003
Citations
Cites
Identification of a nuclear receptor for bile acids
Makishima, M., Okamoto, A. Y., Repa, J. J., Tu, H., Learned, R. M., Luk, A., Hull, M. V., Lustig, K. D., Mangelsdorf, D. J., & Shan, B. (1999) · Science · doi:10.1126/science.284.5418.1362 · Cited by 2,714
Bile Acids: Natural Ligands for an Orphan Nuclear Receptor
Parks, D. J., Blanchard, S. G., Bledsoe, R. K., Chandra, G., Consler, T. G., Kliewer, S. A., Stimmel, J. B., Willson, T. M., Zavacki, A. M., Moore, D. D., et al. (1999) · Science · doi:10.1126/science.284.5418.1365 · Cited by 2,274
Self-citationA regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis
Goodwin, B., Jones, S. A., Price, R. R., Watson, M. A., McKee, D. D., Moore, L. B., Galardi, C., Wilson, J. G., Lewis, M. C., Roth, M. E., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00051-4 · Cited by 1,940
Self-citationTargeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis
Sinal, C. J., Tohkin, M., Miyata, M., Ward, J. M., Lambert, G., & Gonzalez, F. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00062-3 · Cited by 1,819
Self-citationEndogenous Bile Acids Are Ligands for the Nuclear Receptor FXR/BAR
Wang, H., Chen, J., Hollister, K., Sowers, L. C., & Forman, B. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80348-2 · Cited by 1,636
The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity
Staudinger, J. L., Goodwin, B., Jones, S. A., Hawkins-Brown, D., MacKenzie, K. I., LaTour, A., Liu, Y., Klaassen, C. D., Brown, K. K., Reinhard, J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051551698 · Cited by 1,379
Self-citationIdentification of a nuclear receptor that is activated by farnesol metabolites
Forman, B. M., Goode, E., Chen, J., Oro, A. E., Bradley, D. J., Perlmann, T., Noonan, D. J., Burka, L. T., McMorris, T., Lamph, W. W., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90530-8 · Cited by 1,210
Vitamin D Receptor As an Intestinal Bile Acid Sensor
Makishima, M., Lu, T. T., Xie, W., Whitfield, G. K., Domoto, H., Evans, R. M., Haussler, M. R., & Mangelsdorf, D. J. (2002) · Science · doi:10.1126/science.1070477 · Cited by 1,176
An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids
Xie, W., Radominska-Pandya, A., Shi, Y., Simon, C. M., Nelson, M. C., Ong, E. S., Waxman, D. J., & Evans, R. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051014398 · Cited by 757
Maglich, J. M., Stoltz, C. M., Goodwin, B., Hawkins-Brown, D., Moore, J. T., & Kliewer, S. A. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.3.638 · Cited by 654
Self-citation
Research works printed but not linked: 2
- Hofmann, 1995, Ital. J. Gastroenterol., 27, 106
- Seol, 1995, Mol. Endocrinol., 9, 72
Cited by
Items 201–300 of 311
Identification of FDA-approved drugs targeting the Farnesoid X Receptor
van de Wiel, S. M. W., Bijsmans, I. T. G. W., van Mil, S. W. C., & van de Graaf, S. F. J. (2019) · Scientific Reports · doi:10.1038/s41598-019-38668-7 · Cited by 27
Effect of two 5-HT6 receptor antagonists on the rat liver: a molecular approach
Suter, L., Haiker, M., de Vera, M. C., & Albertini, S. (2003) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500207 · Cited by 26
Distinct bile acid alterations in response to a single administration of PFOA and PFDA in mice
Yu, X., Zhang, Y., Cogliati, B., Klaassen, C. D., Kumar, S., Cheng, X., & Bu, P. (2024) · Toxicology · doi:10.1016/j.tox.2023.153719 · Cited by 26
Bile Acids and Biliary Fibrosis
Aseem, S. O., Hylemon, P. B., & Zhou, H. (2023) · Cells · doi:10.3390/cells12050792 · Cited by 34
“In a PXR and FXR double knockout model, CAR expression was increased, and its activation was protective by the modulation of genes involved in bile acid and bilirubin metabolism [108].”
BackgroundOrganic Anion Transporting Polypeptide 1a1 Null Mice Are Sensitive to Cholestatic Liver Injury
Zhang, Y., Csanaky, I. L., Cheng, X., Lehman‐McKeeman, L. D., & Klaassen, C. D. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfs123 · Cited by 24
“FXR, PXR, CAR, PPARa, and Nfr2 are key nuclear receptors that participate in adaptive responses to cholestasis (Guo et al., 2003; Hays et al., 2005; Liu et al., 2003; Okada et al., 2009; Stedman et al., 2005).”
BackgroundMiyata, M., Matsuda, Y., Nomoto, M., Takamatsu, Y., Sato, N., Hamatsu, M., Dawson, P. A., Gonzalez, F. J., & Yamazoe, Y. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.022590 · Cited by 22
“Under conditions of absence of FXR, activated LXR and PXR might suppress hepatic bile acid accumulation to protect liver against CA-induced injury (Guo et al., 2003; Teng and Piquette-Miller, 2007).”
BackgroundSelf-citationTransporters in the intestine limiting drug and toxin absorption
Elferink, R. P. J. O., & de Waart, R. D. (2007) · Journal of Physiology and Biochemistry · doi:10.1007/bf03174087 · Cited by 24
Genetic predisposition of cholesterol gallstone disease
Hernández-Nazará, A., Curiel-López, F., Martínez‐López, E., Nazará, Z., & Panduro, A. (2006) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31997-0 · Cited by 22
“Identified target genes are CYP7A1.”
BackgroundFried, K. W., Guo, G. L., Esterly, N., Kong, B., & Rozman, K. K. (2010) · Drug and Chemical Toxicology · doi:10.3109/01480540903390026 · Cited by 22
“Analysis of mRNA was performed by Northern blot analysis, as published previously (Guo et al., 2003).”
MethodSelf-citationWindshügel, B., Jyrkkärinne, J., Küblbeck, J., Poso, A., Honkakoski, P., & Sippl, W. (2006) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2006.05.002 · Cited by 22
Role of nuclear receptor CAR in carbon tetrachloride-induced hepatotoxicity
Yamazaki, Y., Kakizaki, S., Horiguchi, N., Takagi, H., Mori, M., & Negishi, M. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i38.5966 · Cited by 23
“CAR could act as a protective manner in other situations[30, 31 ].”
BackgroundZhao, J., Yang, Q., Liu, Z., Xu, P., Tian, L., Yan, J., Li, K., Lin, B., Bian, L., Xi, Z., et al. (2023) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2023.114573 · Cited by 20
Perez, M. J., Castaño, B., Jiménez, S., Serrano, M. A., González-Buitrago, J. M., & Marín, J. J. G. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.07.013 · Cited by 18
“FXR, PXR, and CAR protect against hepatic BA toxicity in a complementary manner, suggesting that they serve as a partially redundant defense mechanism to prevent BA-induced hepatic damage during cholestasis (Guo et al., 2003).”
BackgroundChen, F., Zamule, S. M., Coslo, D. M., Chen, T., & Omiecinski, C. J. (2013) · Developmental Biology · doi:10.1016/j.ydbio.2013.10.012 · Cited by 21
“…fate of many drugs (Wei et al., 2000), chemical carcinogens (Xie et al., 2003) as well as endogenous substances such as steroids (Xie et al., 2003), heme and bilirubin (Xie et al., 2003), thyroid hormone (Maglich et al., 2004), and cholesterol/bile acids (Guo et al., 2003; Stedman et al., 2005).”
BackgroundLyons, M. A., & Wittenburg, H. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2006.08.014 · Cited by 17
Sepe, V., Ummarino, R., D’Auria, M. V., Taglialatela‐Scafati, O., Marino, S. D., D’Amore, C., Renga, B., Chini, M. G., Bifulco, G., Nakao, Y., et al. (2012) · Marine Drugs · doi:10.3390/md10112448 · Cited by 18
“These are two nuclear receptors involved in regulating bile acid synthesis as well as in detoxification and excretion in the liver and gastro-intestinal tract [19–22] and therefore important pharmacological targets in the treatment of cholestatic disorders [23–25].”
BackgroundTrauner, M., Jaeschke, H., Mullen, K. D., & Moradpour, D. (2004) · Hepatology · doi:10.1002/hep.20294 · Cited by 18
Li, Z., Zheng, D., Zhang, T., Ruan, S., Li, N., Yang, Y., Yang, P., & Wang, D. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000343 · Cited by 29
Laurenzana, E. M., Chen, T., Kannuswamy, M., Sell, B. E., Strom, S. C., Li, Y., & Omiecinski, C. J. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.080721 · Cited by 19
“More importantly, CAR now is recognized as a regulator of endogenous physiological processes, such as energy, glucose, and lipid homeostasis and bile acid elimination (Guo et al., 2003; Kodama et al., 2004; Konno et al., 2008; Masson et al., 2008).”
BackgroundMarine Ligands of the Pregnane X Receptor (PXR): An Overview
Carazo, A., Mladěnka, P., & Pávek, P. (2019) · Marine Drugs · doi:10.3390/md17100554 · Cited by 17
Ogura, J., Terada, Y., Tsujimoto, T., Koizumi, T., Kuwayama, K., Maruyama, H., Fujikawa, A., Takaya, A., Kobayashi, M., Itagaki, S., et al. (2012) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j38c88 · Cited by 16
“These receptors regulate several metabolizing enzymes and transporters, such as MRP2 (10-14), and coordinately prevent hepatotoxicity (15, 16).”
BackgroundTang, Q., & Evans, R. M. (2021) · Essays in Biochemistry · doi:10.1042/ebc20210038 · Cited by 14
Bile Acid-Induced Liver Injury in Cholestasis
Li, T., & Chiang, J. Y. L. (2017) · Springer eBooks · doi:10.1007/978-3-319-53774-0_7 · Cited by 16
Ji, H., Song, N., Ren, J., Li, W., Zhang, L., Xu, B., Li, H., Shen, G., & Li, H. (2020) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.9b00503 · Cited by 14
The role of the colonic microbiota and bile acids in colorectal cancer
Roberts, D. C., Chidambaram, S., & Kinross, J. K. (2021) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000816 · Cited by 13
“vitamin D receptor, and constitutive androstane receptor (CAR) [14], all found to be activated by BAs or their metabolites.”
BackgroundThe Novel Antibacterial Compound Walrycin A Induces Human PXR Transcriptional Activity
Berthier, A., Oger, F., Gheeraert, C., Boulahtouf, A., Guével, R. L., Balaguer, P., Staels, B., Salbert, G., & Lefèbvre, P. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfs073 · Cited by 12
FXR crosstalk with other nuclear receptors
Mohammed, T. A., & Zalzala, M. H. (2025) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-025-01118-2 · Cited by 15
“This suggests that PXR activation by LCA contributes to liver protection, a conclusion reinforced by studies using PXR-null and transgenic models [87].”
Nonalcoholic Fatty Liver Disease (NAFLD) Name Change: Requiem or Reveille?
Singh, S. P., Anirvan, P., Khandelwal, R., & Satapathy, S. K. (2021) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2021.00174 · Cited by 12
Je, Y.-T., Sim, W.-C., Kim, D.-G., Jung, B.-H., Shin, H., & Lee, B. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1268-9 · Cited by 12
“CAR mediated compensatory induction of Cyp3a11 in cholic acid-fed Pxr/Fxr-double-knockout mice was reported, but there is no evidence to date that endogenous bile acids are CAR ligands (Guo et al. 2003).”
BackgroundThe impact of cholesterol and its metabolites on drug metabolism
Režen, T. (2011) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2011.558083 · Cited by 12
“Feeding FXR/PXR double knockout mice with CA revealed that CAR represents an additional defense line in protection against bile acid toxicity in the liver [67].”
BackgroundBRAVO, I., AMIGO, L., Cohen, D. A., Nervi, F. O., Rigotti, A., Francone, O. L., & Zanlungo, S. (2007) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2007.02.010 · Cited by 12
Nuclear receptor ligands in therapy of cholestatic liver disease
Sturm, E., Wagner, M., & Trauner, M. (2009) · Frontiers in bioscience · doi:10.2741/3529 · Cited by 12
“4309 role of Car in bile acid detoxification (224).”
BackgroundThompson, E. E., Kuttab-Boulos, H., Krasowski, M. D., & Rienzo, A. D. (2005) · Human Genomics · doi:10.1186/1479-7364-2-3-168 · Cited by 12
Chow, M. D., Otersen, K., Wassef, A. M., Kong, B., Yamarthy, S., Rizzolo, D., Yang, I., Buckley, B., Lu, A., Crook, N., et al. (2024) · Hepatology Communications · doi:10.1097/hc9.0000000000000444 · Cited by 11
Self-citationBoyer, J. L. (2009) · Hepatology · doi:10.1002/hep.22719 · Cited by 11
Differential modulation of FXR activity by chlorophacinone and ivermectin analogs
Hsu, C.-W., Hsieh, J., Huang, R., Pijnenburg, D., Khuc, T., Hamm, J. T., Zhao, J., Lynch, C., van Beuningen, R., Chang, X., et al. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.10.017 · Cited by 11
“In addition to FXR, constitutive androstane receptor (CAR), liver X receptor (LXR), and pregnane X receptor (PXR) also heterodimerize with the RXR and regulate transcription of genes involved in bile acid (Guo et al., 2003) and lipid (Handschin and Meyer, 2005) homeostasis, complicating interpretation of the results g…”
BackgroundŠkoda, J., Dohnalová, K., Chalupský, K., Stahl, A., Templin, M. F., Maixnerová, J., Mičuda, S., Grøntved, L., Braeuning, A., & Pávek, P. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114905 · Cited by 12
Kosters, A., Felix, J. C., Desai, M. S., & Karpen, S. J. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.09.026 · Cited by 12
“However hepatic response individual knockout mice for these BA-activated NRs respond differently compared to the CA-fed hs-RxrαΔex4-/-[29-32].”
BackgroundFang, M., Qi, Z., Yu, P., Ge, C., Guo, J., Zhang, Y., & Wang, H. (2020) · Toxicology Letters · doi:10.1016/j.toxlet.2020.06.011 · Cited by 10
Adaptive Regulation of Hepatocyte Transporters in Cholestasis
Boyer, J. L. (2009) · Wiley eBooks · doi:10.1002/9780470747919.ch43 · Cited by 10
Kim, D., Na, K., & Choi, J. (2024) · Chemosphere · doi:10.1016/j.chemosphere.2024.143772 · Cited by 9
Regulation of Hepatobiliary Transporters during Liver Injury
Manautou, J. E., Campion, S. N., & Aleksunes, L. M. (2010) · Elsevier eBooks · doi:10.1016/b978-0-08-046884-6.01008-3 · Cited by 10
Garduño‐Siciliano, L., Labarrios, F., Tamariz, J., Moreno, M. G., Chamorro, G., & Muriel, P. (2006) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2006.00453.x · Cited by 8
Min, G. (2010) · Experimental & Molecular Medicine · doi:10.3858/emm.2010.42.11.074 · Cited by 9
Komichi, D., Tazuma, S., Nishioka, T., Hyogo, H., & Chayama, K. (2005) · Digestive Diseases and Sciences · doi:10.1007/s10620-005-2467-2 · Cited by 8
Mechanisms of Hepatocyte Organic Anion Transport
Wolkoff, A. W. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-382026-6.00054-3 · Cited by 8
Huillet, M., Lasserre, F., Gratacap, M., Engelmann, B., Bruse, J., Polizzi, A., Fougeray, T., Martin, C. M. P., Rives, C., Fougerat, A., et al. (2023) · JHEP Reports · doi:10.1016/j.jhepr.2023.100930 · Cited by 12
“42,43 As previously described, we found that the expression of genes involved in hydroxylation, sulfation, and excretion of bile acids was signi fi - cantly enhanced upon CAR activation, whereas expression of genes involved in bile acid synthesis and cholesterol transport was decreased in both sexes.”
BackgroundZhu, Y., Li, G., Dong, Y., Zhou, H. H., Kong, B., Aleksunes, L. M., Richardson, J. R., Li, F., & Guo, G. L. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.11.012 · Cited by 8
“FXR regulates several key hepatic functions including bile acid, cholesterol and lipid homeostasis and glucose metabolism (Guo et al., 2003; Lambert et al., 2003; Ma et al., 2006; Mak et al., 2002; Sinal et al., 2000; Sirvent et al., 2004; Zhang et al., 2006).”
BackgroundSelf-citationConstitutive Androstane Receptor
DeKeyser, J. G., & Omiecinski, C. J. (2010) · Elsevier eBooks · doi:10.1016/b978-0-08-046884-6.00211-6 · Cited by 7
Li, D., Xiao, G., Chen, W., Zeng, X., Cao, L.-Z., & Chen, Z. (2022) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2022.104272 · Cited by 6
Xenobiotic and endobiotic handling by the mucosal immune system
Chen, M. L., & Sundrud, M. S. (2018) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000478 · Cited by 7
Urban, T. J., & Giacomini, K. M. (2006) · Wiley eBooks · doi:10.1002/9780470140505.ch2 · Cited by 6
Xenobiotic Receptors CAR and PXR
Klaassen, C. D., & Lü, H. (2010) · Springer eBooks · doi:10.1007/978-90-481-3303-1_11 · Cited by 5
Boden, G. H., Scapa, E. F., Kanno, K., Cohen, D. E., Brosnan, M. E., Brosnan, J. T., Pessayre, D., Roy‐Chowdhury, N., Lu, Y., Roy‐Chowdhury, J., et al. (2007) · Wiley eBooks · doi:10.1002/9780470691861.ch2c · Cited by 9
Microbiota–gut–brain axis and bile acids–driven neuromodulation
Dong, T., Zhang, T., Wang, H., Zhang, J., Abdullah, R., Sun, B., & Peng, G. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-00927 · Cited by 8
Mohammed, T. A., & Zalzala, M. H. (2025) · Current Pharmacology Reports · doi:10.1007/s40495-025-00404-3 · Cited by 4
Kosar, K., Cornuet, P. K., Singh, S., Liu, S., & Nejak‐Bowen, K. N. (2020) · American Journal Of Pathology · doi:10.1016/j.ajpath.2020.01.015 · Cited by 4
“FXR and its downstream target small heterodimer partner are master regulators of BA synthesis, whereas pregnane X receptor and constitutive androstane receptor regulate expression of cytochrome P450 (Cyp) genes involved in detoxifying and transporting BAs.19,20 This study found that GC-1 reduced expression of FXR afte…”
ResultMechanism for Increased Expression of UGT2B in the Liver of Mice with Neuropathic Pain
Kaneta, M., Ochiai, W., Nagae, M., Suto, W., Hanagata, M., Suzuki, H., Kitaoka, S., Hatogai, J., Ikarashi, N., & Sugiyama, K. (2016) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b16-00341 · Cited by 4
Regulation of Hepatobiliary Transporters During Liver Injury
Manautou, J. E., & Ghanem, C. I. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.95661-7 · Cited by 3
Jansen, P. L. M., Beuers, U. H., & Elferink, R. P. J. O. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0881-3.00004-8 · Cited by 4
Jungsuwadee, P., & Vore, M. E. (2010) · Elsevier eBooks · doi:10.1016/b978-0-08-046884-6.00426-7 · Cited by 5
Nuclear Receptors in Energy Metabolism
Walth-Hummel, A. A., Herzig, S., & Rohm, M. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-11836-4_4 · Cited by 5
Up-to-Date Snapshot of Current and Emerging Medical Therapies in Primary Biliary Cholangitis
Warsop, Z. I., Anand, N., Maliki, H. A., Souza, S. D., Kamyab, A. A., Hadad, A. A., & Alrubaiy, L. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14121133 · Cited by 4
“The consequent reduced hepatic bile acid accumulation prevents bile acid toxicity, leading to less cholestatic injury (Figure 1) [47,48].”
Molecular mechanisms of cholestasis
Trauner, M., Fickert, P., Halilbasic, E., Wagner, M., & Zollner, G. (2007) · Springer eBooks · doi:10.1007/1-4020-4144-6_20 · Cited by 3
Fukumasu, H. (2008) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.10.2008.tde-30042009-162117 · Cited by 10
Jansen, P. L. M., & Groen, A. K. (2006) · Elsevier eBooks · doi:10.1016/b978-1-4160-3258-8.50010-3 · Cited by 2
Elucidating the mechanism behind the lipid-raising effect of cafestol
Boekschoten, M. V. (2004) · doi:10.18174/39059 · Cited by 3
“The serum cholesterol response to dietary changes differs considerably between subjects, while the response is to some extent reproducible within subjects (40-44).”
BackgroundEffect of serum cholesterol on the mRNA content of amyloid precursor protein in rat livers
Kiyosawa, N., Ito, K., Niino, N., Sakuma, K., Kanbori, M., Yamoto, T., Manabe, S., & Matsunuma, N. (2004) · Toxicology Letters · doi:10.1016/j.toxlet.2004.01.004 · Cited by 2
Mechanisms of Hepatocyte Organic Anion Transport
Wolkoff, A. W. (2006) · Elsevier eBooks · doi:10.1016/b978-012088394-3/50060-x · Cited by 2
A Polymorphism in the FGF21 Gene is a Novel Risk Variant for Metabolic-Associated Steatohepatitis
Elsayed, A. (2020) · The Sydney eScholarship Repository (The University of Sydney) · Cited by 3
Lickteig, A. J. (2007) · UA Campus Repository (The University of Arizona) · Cited by 2
In vitro evidence of possible influence of scutellarein towards bile acids’ metabolism
Shu-Yao, Z., Hong, J., Chao-xian, L., Zhi-Wei, Z., Xin, D., & Lei, C. (2013) · African Health Sciences · doi:10.4314/ahs.v13i3.4 · Cited by 1
PXR mediated cardiac protection after sepsis through TLR4 modulation pathway
Huska, S. F., Ade, M. H., & Zhou, A. (2015) · American Journal of BioMedicine · doi:10.18081/2333-5106/015-569-581 · Cited by 1
Fukumasu, H., Rochetti, A. L., Latorre, A. O., Pires, P. R. L., Silva, T. C., & Dagli, M. L. (2015) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s1984-82502015000200006 · Cited by 1
The Role of Cholesterol in the Pathogenesis of Hypertension- Associated Nonalcoholic Steatohepatitis
Yuan, Y., Naito, H., & Nakajima, T. (2018) · InTech eBooks · doi:10.5772/intechopen.76199 · Cited by 1
Constitutive Androstane Receptor
Yan, J., & Xie, W. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.95606-x · Cited by 1
Mechanisms of Hepatocyte Organic Anion Transport
Wolkoff, A. W. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809954-4.00042-6 · Cited by 1
Mechanisms of Proinflammatory Signaling during Cholestasis
Allen, K. M. (2011) · KU ScholarWorks (The University of Kansas) · Cited by 1
Adaptive Regulation of Hepatocyte Transporters in Cholestasis
Boyer, J. L. (2020) · Wiley eBooks · doi:10.1002/9781119436812.ch31 · Cited by 1
Huillet, M., Frédéric, L., Gratacap, M., Engelmann, B., Bruse, J., Arnaud, P., Tiffany, F., Céline, M., Rives, C., Fougerat, A., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.17.537169 · Cited by 1
Zhou, W., Chembazhi, U. V., Huang, J., Bangru, S., Dean, A. E., Asokakumar, A., Kalsotra, A., Rudnick, D. A., & Anakk, S. (2026) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2026.101858
“54,55 In fact, the BA–FXR axis was shown to induce detoxification genes in the livers of long-lived Little mice rather than CAR and PXR, 56 indicative of crosstalk between these nuclear receptors.”
Beyond PXR and CAR, Regulation of Xenobiotic Metabolism by other Nuclear Receptors
Wagner, M., Zollner, G., & Trauner, M. (2008) · Wiley eBooks · doi:10.1002/9780470409107.ch10
de Waart, D. R., & Elferink, R. P. J. O. (2009) · Methods and principles in medicinal chemistry · doi:10.1002/9783527627424.ch11
Intestinal function in cholestasis and essential fatty acid deficiency
Los, E. (2007) · University of Groningen research database (University of Groningen / Centre for Information Technology)
Integration of Systems Toxicology into Drug Discovery
Fielden, M. R. (2009) · Wiley eBooks · doi:10.1002/9780470744307.gat210
Schillinger, K. J., Tsai, S. Y., & Tsai, M. (2007) · Springer eBooks · doi:10.1007/978-0-387-40049-5_16
Behazun-gatzen garraioaren fisiologia
Rueda, Y., Apichueta, P., & Fresnedo, O. (2011) · EKAIA Euskal Herriko Unibertsitateko Zientzi eta Teknologi Aldizkaria · doi:10.1387/ekaia.6802
“Gainera, CAR-en eraginez BG-en, bilirrubinaren eta xenobiotikoen metabolismo eta iraizketan parte hartzen duten zenbait generen adierazpena sustatzen da: Cyp2b10, Cyp3a11, Mrp2, Mrp3, Mrp4, Oatp2 eta destoxifikatu behar diren molekulen konjokatu hidrofilikoak sortzen dituen zenbait entzima [99, 105, 106] (6 irudia).”
BackgroundHepatic stellate cell transdifferentiation: Pro-fibrogenic effectors
Lakner, A. M., & NC DOCKS at The University of North Carolina at Charlotte (2011) · NC Digital Online Collection of Knowledge and Scholarship (The University of North Carolina at Greensboro)
Regulation of ABCA1 in hepatocytes by the nuclear receptor PXR
Tapia, G. (2005) · NORA - Norwegian Open Research Archives
Human Pregnane X Receptor (hPXR) Activation Assay in Stable Cell Lines
Raucy, J. L. (2013) · Methods in pharmacology and toxicology · doi:10.1007/978-1-62703-742-6_10
“It was previously reported [ 28 , 29 ] that mice expressing constitutively activated PXR displayed hepatomegaly and marked hepatic steatosis, and that rifampicin treatment of mice possessing a human PXR gene resulted in hepatic triglyceride accumulation [ 30 ].”
BackgroundLyons, M. A., & Wittenburg, H. (2006)
Makishima, M. (2017) · Springer eBooks · doi:10.1007/978-4-431-56062-3_4
Goodman, R. P. (2018) · Ulster University Research Portal (Ulster University)
[Advances in medical therapy of hypertension].
Orbegozo, J. M. R. (1953) · PubMed
Bile Acids and Bilirubin in Liver Immunology
Zhu, C., Claudel, T., & Trauner, M. (2020) · Springer eBooks · doi:10.1007/978-3-030-51709-0_7
Nukleäre Rezeptoren beim hepatischen und intestinalen Medikamententransport
Kullak-Ublick, G. A. (2021) · Drug Research · doi:10.1055/a-1606-5609
“Auch MRP3 scheint durch PXR, CAR und FXR induzierbar zu sein [13].”
BackgroundKarlsen, T. H., Boberg, K. M., & Schrumpf, E. (2007) · Springer eBooks · doi:10.1007/978-1-4020-6252-0_31
Eloranta, J. J., Stieger, B., & Kullak-Ublick, G. A. (2014) · Wiley eBooks · doi:10.1002/9781118705308.ch8
Metadata
- Authors
- Guo, G. L., Lambert, G., Negishi, M., Ward, J. M., Brewer, H. B., Kliewer, S. A., Gonzalez, F. J., & Sinal, C. J.
- Affiliations
- National Institutes of Health (US)
- Inserm (FR)
- National Cancer Institute (US)
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Gonzalez, Frank J.
- ORCID
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-11
- Volume
- 278
- Issue
- 46
- Pages
- 45062-45071
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2168485100
- Cited by
- 312
- References
- 37
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 7 · 2023: 10 · 2022: 7 · 2021: 8 · 2020: 10 · 2019: 9 · 2018: 9 · 2017: 10 · 2016: 6 · 2015: 6 · 2014: 9 · 2013: 20 · 2012: 13
- FWCI
- 11.57
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6175 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Keywords
- farnesoid X receptor, pregnane X receptor, constitutive androstane receptor, bile acid toxicity, cholic acid, bile acid homeostasis, cholesterol homeostasis, lipid homeostasis, cholestasis, bilirubin metabolism, phenobarbital, TCPOBOP, CYP2B, CYP3A, MRP2, MRP3, UGT1A, alpha-glutathione S-transferase
- MeSH terms
- Pregnane X Receptor, Constitutive Androstane Receptor, Receptor, Farnesoid X-Activated, Animals, Animal Feed, Aryl Hydrocarbon Hydroxylases, Bile Acids and Salts, Bilirubin, Biological Transport, Body Weight, Cell Nucleus, Cholesterol, Cloning, Molecular, Crosses, Genetic, DNA-Binding Proteins, Glutathione Transferase, Liver, Mice, Transgenic, Oxidoreductases, N-Demethylating, Phenobarbital, Phospholipids, Pyridines, Receptors, Steroid, Ribosomal Proteins, Time Factors, Transcription Factors, Blotting, Northern, Up-Regulation, Gene Deletion, Receptors, Cytoplasmic and Nuclear, Mitochondrial Proteins, Saccharomyces cerevisiae Proteins, Lipid Metabolism, Mice, Cytochrome P-450 CYP3A
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.